# Safety and Efficacy of Adaptive DBS Vs Conventional DBS in Patients With Parkinson's Disease

> **NCT03422757** · NA · TERMINATED · sponsor: **Newronika** · enrollment: 6 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DEVICE:** adaptive Deep Brain Stimulation
- **DEVICE:** conventional Deep Brain Stimulation

## Key facts

- **NCT ID:** NCT03422757
- **Lead sponsor:** Newronika
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Company strategic decision
- **Last updated:** 2020-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03422757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03422757, "Safety and Efficacy of Adaptive DBS Vs Conventional DBS in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03422757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*